Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SONOCO PRODUCTS COSON · Entity 3864 | Director | October 01, 2026 | October 05, 2026 |
| TIMKEN COTKR · Entity 1862 | Director | August 10, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SONOCO PRODUCTS CO
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 31,973 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 747.4 · Balance 31,973 F1: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock.
F2: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement.
TIMKEN CO
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 183,724 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Sale · Disposed 13,637 · Balance 183,724 F1: This transaction was executed in multiple trades at prices ranging from $126.40 to $127.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $126.40 to $127.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Sotera Health Co
Report date May 22, 2026 · Filed May 27, 2026
Section 16 reporting ended · disclosed 2026-02-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivative | Direct | 14,970 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 14,970 · Balance 14,970 F1: These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities consist of 14,970 restricted stock units ("RSUs") that were granted on May 22, 2026, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incenctive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 03, 2017 Filed Jul 7, 2017 15:51 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 533.3 | $51.57 | $27,502.28 |
DisclosureSEC source: 0001225208-17-012418 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,004.2 Underlying: Common Stock · 533.3 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. F2 · derivative.expiration_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 20:02 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 26.5 | $50.70 | $1,343.55 |
DisclosureSEC source: 0001225208-17-011225 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,470.9 Underlying: Common Stock · 26.5 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. F2 · derivative.expiration_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 17:26 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 524.2 | $52.46 | $27,499.53 |
DisclosureSEC source: 0001225208-17-007256 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444.4 Underlying: Common Stock · 524.2 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. F2 · derivative.expiration_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 20:38 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 20.1 | $53.33 | $1,071.93 |
DisclosureSEC source: 0001225208-17-006226 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,920.2 Underlying: Common Stock · 20.1 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. F2 · derivative.expiration_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | GrantEmployee Stock Option (right to buy) · Derivative | 117,750 | $0.00 Strike: $45.35 | $0.00 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · derivative · entry 8 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,750 Underlying: Common Stock · 117,750 shares Expires 2027-02-13 F5 · derivative.exercise_date: These options will become exercisable in annual 25% increments beginning on February 13, 2018. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | GrantRestricted Share Unit · Derivative | 45,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · derivative · entry 7 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,875 Underlying: Common Stock · 45,875 shares Expires 2019-12-31 F4 · derivative.exercise_date: Grant of 45,875 performance-based restricted share units subject to certain performance criteria between January 1, 2017 and December 31, 2019. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | GrantRestricted Share Unit · Derivative | 18,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · derivative · entry 6 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,350 Underlying: Common Stock · 18,350 shares Expires 2021-02-13 F3 · derivative.exercise_date: Grant of 18,350 time-based restricted share units that vest 25% per year. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 23:02 UTC | TIMKEN CO TKR · Entity 1862 | Tax withholdingCommon Stock | 11,947 | $45.85 | $547,769.95 |
DisclosureSEC source: 0000098362-17-000025 · wf-form4_148719973942379.xml · nonDerivative · entry 2 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,999 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 23:02 UTC | TIMKEN CO TKR · Entity 1862 | GrantCommon Stock | 29,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000098362-17-000025 · wf-form4_148719973942379.xml · nonDerivative · entry 1 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,946 F1 · security: Represents vesting of 100% of the cliff vested restricted share units granted on February 13, 2014 and previously reported on Form 4. Read SEC document |
| February 12, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | Tax withholdingCommon Stock | 1,580 | $45.20 | $71,416.00 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · nonDerivative · entry 4 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,546 Read SEC document |
| February 12, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | GrantCommon Stock | 5,119 | $0.00 | $0.00 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · nonDerivative · entry 3 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,126 F2 · security: Represents vesting of 25% of the restricted share units granted on February 12, 2015. Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | Tax withholdingCommon Stock | 2,259 | $45.20 | $102,106.80 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · nonDerivative · entry 2 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,007 Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 18:47 UTC | TIMKEN CO TKR · Entity 1862 | GrantCommon Stock | 7,168 | $0.00 | $0.00 |
DisclosureSEC source: 0000098362-17-000013 · wf-form4_148709803164890.xml · nonDerivative · entry 1 Kyle Richard G · CIK 0001507947 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,266 F1 · security: Represents vesting of 25% of the restricted share units granted on February 11, 2016. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:28 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 515.7 | $53.33 | $27,502.28 |
DisclosureSEC source: 0001225208-17-000697 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900.1 Underlying: Common Stock · 515.7 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. F2 · derivative.expiration_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 22:21 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 16.2 | $54.01 | $874.96 |
DisclosureSEC source: 0001225208-16-043094 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,384.4 Underlying: Common Stock · 16.2 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. F2 · derivative.expiration_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 19:48 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 540.6 | $50.87 | $27,500.32 |
DisclosureSEC source: 0001225208-16-039998 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,368.2 Underlying: Common Stock · 540.6 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. F2 · derivative.expiration_date: The phantom stock units were accrued under the Sonoco Products Company directors deferred compensation plan and are to be settled in Sonoco Products Company common stock 6 months after the reporting person's retirement. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 21:00 UTC | SONOCO PRODUCTS CO SON · Entity 3864 | GrantPhantom Stock Units · Derivative | 13.1 | $51.10 | $669.41 |
DisclosureSEC source: 0001225208-16-039316 · doc4.xml · derivative · entry 1 Kyle Richard G · CIK 0001507947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,827.6 Underlying: Common Stock · 13.1 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Sonoco Products Company common stock. F2 · derivative.exercise_date: Acquired on quarterly dividend on Sonoco Products Company's directors' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. F3 · derivative.expiration_date: Acquired on quarterly dividend on Sonoco Products Company's officers' deferred compensation plan and will be settled upon the reporting person's retirement or other termination of service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.